The NVL gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 62, Issue , 2015, Pages 7-13

  Wang, Meng ^a   Chen, Jianhua ^a,b   He, Kuanjun ^c   Wang, Qingzhong ^b   Li, Zhiqiang ^a   Shen, Jiawei ^a   Wen, Zujia ^a   Song, Zhijian ^a   Xu, Yifeng ^b   Shi, Yongyong ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

^d Changning Mental Health Center   (China)

Author keywords

Association; Major depressive disorder; NVL gene; Schizophrenia; Telomerase activity

Indexed keywords

TELOMERASE; ADENOSINE TRIPHOSPHATASE; NVL PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BIOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOLECULAR PATHOLOGY; NVL GENE; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE;

ADENOSINE TRIPHOSPHATASES; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84928685262     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.04.001     Document Type: Article

References (54)

1. Aviv A. How long should telomeres be?. Curr Hypertens Rep 2001, 3:145-151.
2. Babizhayev M.A., Savel'yeva E.L., Moskvina S.N., Yegorov Y.E. Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior. Am J Ther 2011, 18:e209-e226.
3. Barrett E.L., Richardson D.S. Sex differences in telomeres and lifespan. Aging Cell 2011, 10:913-921.
4. Blackburn E.H. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 2005, 579:859-862.
5. Burmeister M., McInnis M.G., Zöllner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008, 9:527-540.
6. Calado R.T., Young N.S. Telomere diseases. N Engl J Med 2009, 361:2353-2365.
7. Caporaso G.L., Lim D.A., Alvarez-Buylla A., Chao M.V. Telomerase activity in the subventricular zone of adult mice. Mol Cell Neurosci 2003, 23:693-702.
8. Collins K. The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol 2006, 7:484.
9. Colton C.W., Manderscheid R.W. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006, 3:A42.
10. Craddock N., Forty L. Genetics of affective (mood) disorders. Eur J Hum Genet 2006, 14:660-668.
11. Damjanovic A.K., Yang Y., Glaser R., Kiecolt-Glaser J.K., Nguyen H., Laskowski B., et al. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007, 179:4249-4254.
12. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005, 37:1217-1223.
13. de Bakker P.I., Burtt N.P., Graham R.R., Guiducci C., Yelensky R., Drake J.A., et al. Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet 2006, 38:1298-1303.
14. Effros R.B. Telomerase induction in T cells: a cure for aging and disease?. Exp Gerontol 2007, 42:416-420.
15. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004, 101:17312-17315.
16. Falush D., Stephens M., Pritchard J.K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003, 164:1567-1587.
17. Falush D., Stephens M., Pritchard J.K. Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes 2007, 7:574-578.
18. Germain-Lee E.L., Obie C., Valle D. NVL: a new member of the AAA family of ATPases localized to the nucleus. Genomics 1997, 44:22-34.
19. Gibbs R.A., Belmont J.W., Hardenbol P., Willis T.D., Yu F., Yang H., et al. The international HapMap project. Nature 2003, 426:789-796.
20. He K., Liu J., Wang Q., Chen J., Li T., Li Z., et al. ITIH family genes confer risk to schizophrenia and major depressive disorder in the Han Chinese population. Prog Neuropsychopharmacol Biol Psychiatry Jun 3 2014, 51:34-38. [Epub 2014 Jan 2]. 10.1016/j.pnpbp.2013.12.004.
21. Her J., Chung I.K. The AAA-ATPase NVL2 is a telomerase component essential for holoenzyme assembly. Biochem Biophys Res Commun 2012, 417:1086-1092.
22. Hoen P.W., de Jonge P., Na B.Y., Farzaneh-Far R., Epel E., Lin J., et al. Depression and leukocyte telomere length in patients with coronary heart disease: data from the heart and soul study. Psychosom Med 2011, 73:541-547.
23. Hubisz M.J., Falush D., Stephens M., Pritchard J.K. Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour 2009, 9:1322-1332.
24. Kao H., Cawthon R., Delisi L., Bertisch H., Ji F., Gordon D., et al. Rapid telomere erosion in schizophrenia. Mol Psychiatry 2008, 13:118-119.
25. King B.H., Lord C. Is schizophrenia on the autism spectrum?. Brain Res 2011, 1380:34-41.
26. Kinser P.A., Lyon D.E. Major depressive disorder and measures of cellular aging: an integrative review. Nurs Res Pract 2013, 2013.
27. Klapper W., Shin T., Mattson M.P. Differential regulation of telomerase activity and TERT expression during brain development in mice. J Neurosci Res 2001, 64:252-260.
28. Kupfer D.J., Frank E., Phillips M.L. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012, 379:1045-1055.
29. Levinson D.F., Duan J., Oh S., Wang K., Sanders A.R., Shi J., et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011, 168:302-316.
30. Li T., Zeng Z., Zhao Q., Wang T., Huang K., Li J., et al. FoxP2 is significantly associated with schizophrenia and major depression in the Chinese Han population. World J Biol Psychiatry 2013, 14:146-150.
31. Lung F.W., Chen N.C., Shu B.C. Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatr Genet 2007, 17:195-199.
32. Luo X., Li M., Huang L., Steinberg S., Mattheisen M., Liang G., et al. Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. Mol Psychiatry Jul 2014, 19(7):774-783. [Epub 2013 Aug 20]. 10.1038/mp.2013.103.
33. Mattson M.P., Fu W., Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech Ageing Dev 2001, 122:659-671.
34. Nagahama M., Hara Y., Seki A., Yamazoe T., Kawate Y., Shinohara T., et al. NVL2 is a nucleolar AAA-ATPase that interacts with ribosomal protein L5 through its nucleolar localization sequence. Mol Biol Cell 2004, 15:5712-5723.
35. Nagahama M., Yamazoe T., Hara Y., Tani K., Tsuji A., Tagaya M. The AAA-ATPase NVL2 is a component of pre-ribosomal particles that interacts with the DExD/H-box RNA helicase DOB1. Biochem Biophys Res Commun 2006, 346:1075-1082.
36. Neuwald A.F., Aravind L., Spouge J.L., Koonin E.V. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res 1999, 9:27-43.
37. Ng M., Levinson D., Faraone S., Suarez B., DeLisi L., Arinami T., et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 2008, 14:774-785.
38. O'Donovan M.C., Craddock N.J., Owen M.J. Genetics of psychosis; insights from views across the genome. Hum Genet 2009, 126:3-12.
39. Ogura T., Wilkinson A.J. AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 2001, 6:575-597.
40. Porton B., DeLisi L.E., Bertisch H.C., Ji F., Gordon D., Li P., et al. Telomerase levels in schizophrenia: a preliminary study. Schizophr Res 2008, 106:242-247.
41. Psychiatric Genetic Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
42. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
43. Rapoport J., Chavez A., Greenstein D., Addington A., Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 2009, 48:10-18.
44. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011, 43:969.
45. Ripke S., Wray N.R., Lewis C.M., Hamilton S.P., Weissman M.M., Breen G., et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2012, 18:497-511.
46. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013, 45:1150-1159.
47. Rudolph K.L., Chang S., Lee H.-W., Blasco M., Gottlieb G.J., Greider C., et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
48. Simon N.M., Smoller J.W., McNamara K.L., Maser R.S., Zalta A.K., Pollack M.H., et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006, 60:432-435.
49. Sklar P., Ripke S., Scott L.J., Andreassen O.A., Cichon S., Craddock N., et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011, 43:977.
50. Wolkowitz O.M., Reus V.I., Mellon S.H. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci 2011, 13:25.
51. Wolkowitz O.M., Mellon S.H., Epel E.S., Lin J., Reus V.I., Rosser R., et al. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry 2012, 17:164-172.
52. Yong Y., Lin H. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
53. Yu W.-Y., Chang H.-W., Lin C.-H., Cho C.-L. Short telomeres in patients with chronic schizophrenia who show a poor response to treatment. J Psychiatry Neurosci 2008, 33:244.
54. Zhang J., Kong Q., Zhang Z., Ge P., Ba D., He W. Telomere dysfunction of lymphocytes in patients with Alzheimer disease. Cogn Behav Neurol 2003, 16:170-176.